GlassScriptPhysician profile
Cedric Griffin
NPI 1194216176
$1,001.45
in general payments reported to CMS, 2019-2025
9 companies · $140 in 2025
The $140 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2020: $37.48 · 2021: $54.88 · 2022: $289 · 2023: $333 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $473.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $473.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $300.96 | 2022-2025 | Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $155.48 | 2020-2023 | Arexvy |
| Astrazeneca Pharmaceuticals LP | $114.33 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $106.74 | 2022 | |
| Abbvie INC. | $98.23 | 2023 | |
| Mylan Specialty L.P. | $97.97 | 2019-2021 | |
| Pfizer INC. | $60.25 | 2019-2025 | |
| Allergan, INC. | $51.58 | 2019 | |
| Sk Life Science, INC. | $15.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cedric Griffin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.